| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |